Everything on this site is supplied as a laboratory reference material for in-vitro research use only. Nothing here is a medicine, and nothing here is licensed for administration to humans or animals.
By entering you confirm you are aged 18 or over, that you are acquiring these materials for legitimate research purposes, and that you will not administer them to any person or animal.
The Wolverine Stack combines BPC-157, a stable gastric pentadecapeptide, with TB-500, the active fragment of thymosin beta-4, in a single vial for combined tissue-repair and angiogenesis research.
Each vial is produced by solid-phase synthesis, purified by reverse-phase HPLC and verified by mass spectrometry before release. Purity and identity for both components are published on the certificate of analysis.
BPC-157 is a pentadecapeptide derived from a fragment of human gastric juice protein, widely used in research into gut lining integrity, tendon and ligament repair, and angiogenesis. TB-500 is a synthetic fragment of Thymosin Beta-4, studied for its role in actin regulation, cell migration and wound-healing models. Combining the two is a common protocol in tissue-repair research literature, where the peptides are proposed to act on overlapping but distinct repair pathways.
Reconstitute with bacteriostatic water. The table shows the concentration and syringe volume produced by common dilutions of a 10mg vial, for reference when preparing research stock solutions.
BPC-157 + TB-500 in a single vial, ratio stated above.